Profil
Tomas L.
Lindahl founded Diapensia HB in 1992, where he is working as Chief Executive Officer from 1992.
Mr. Lindahl also currently works at Nordic Haemostasis AB, as Chairman and MediRox AB, as Independent Director from 2014.
Postes actifs de Tomas L. Lindahl
| Sociétés | Poste | Début |
|---|---|---|
| MEDIROX AB | Directeur/Membre du Conseil | 01/08/2014 |
| Diapensia HB | Directeur Général | 01/01/1992 |
| Nordic Haemostasis AB | Président | - |
Expériences
Fonctions occupées
Relations
13
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
MediRox AB
 MediRox AB Pharmaceuticals: MajorHealth Technology MediRox AB engages in developing, manufacturing and marketing of control plasmas and diagnostic reagents for coagulation analytes. Its products include PT, APTT, AT, TT, Fib Clauss and D-Dimer within the field of haemostasis. The company was founded in 1998 and is headquartered in Nykoping, Sweden. | Health Technology |
| Diapensia HB | |
| Nordic Haemostasis AB |